Robin Meng

Robin Meng is a Senior Clinical Director at Merck, based in Pennsylvania, focusing on women's cancers, specifically endometrial cancer. With 15 years of industry experience, they have a strong background in clinical development across Phase I-III trials, competitive strategy planning, and medical affairs. Previously, Robin served as a Medical Director at AstraZeneca Taiwan and led various oncology product trials and strategies in their roles at organizations like Sanofi and APEX International Clinical Research. They hold a PhD in Gynecological Oncology from Tianjin Medical University and completed a Global Clinical Scholars Research Training Program at Harvard Medical School.